The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at KRW 144500 KRW in weekly data.
The stock, which is currently worth 2020 to 205.84 times its sales, is clearly overvalued in comparison with peers.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company does not generate enough profits, which is an alarming weak point.
The group usually releases earnings worse than estimated.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Below the resistance at 190000 KRW, the stock shows a negative configuration when looking looking at the weekly chart.